Article
Physician use of genetic testing for cancer susceptibility: results of a national survey.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2003
Wideroff Louise, Freedman Andrew N, Olson Lorayn, Klabunde Carrie N, Davis William, Srinath Kadaba P, Croyle Robert T, Ballard-Barbash Rachel
Abstract excerpt
Genetic testing for inherited germ-line mutations associated with cancer susceptibility is an emerging technology in medical practice. Limited information is currently available about physician use of cancer susceptibility tests (CSTs). In 1999-2000, a nationally representative survey was conducted to estimate prevalence of CST use by United States physicians and assess demographic, training, practice setting,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.